People · Operator
Named in public records as an officer, director or promoter · active 2008–2011 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Velomedix, Inc. | — | Biotechnology | Series A | $27.3M | $335.9M | 2009 |
| Access Closure, Inc. | — | Other | Series A | $23.6M | $15.6M | 2008 |
Jeff Gold at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeff Gold on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| FARHAD KHOSRAVI | 1 | 14 |
| David Martin | 1 | 13 |
| Daniel Burnett | 1 | 11 |
| Mark Wan | 1 | 10 |
| Jeani Delagardelle | 1 | 8 |
| Amar Sawhney | 1 | 6 |
| Hank Plain | 1 | 5 |
| Jeffrey Lightcap | 1 | 5 |
| John Dean | 1 | 5 |
| Andrew Cleeland | 1 | 5 |
| J. Casey McGlynn | 1 | 5 |
| Casey McGlynn | 1 | 3 |
| Ken Ludlum | 1 | 3 |
| Rob Kuhling | 1 | 3 |
| Jim Dennis | 1 | 2 |
| ROB L. KUHLING | 1 | 2 |
| Marc Galletti | 1 | 2 |
| JEFFREY L. LIGHTCAP | 1 | 2 |
| NELSON L. HOPKINS | 1 | 1 |
| JOHN L. BUCKLEY | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.